NZ189503A - Diastereomers of erythro-2-(2-aralkylamino-1-hydroxy-ethyl)-1,4-benzodioxanes - Google Patents

Diastereomers of erythro-2-(2-aralkylamino-1-hydroxy-ethyl)-1,4-benzodioxanes

Info

Publication number
NZ189503A
NZ189503A NZ189503A NZ18950379A NZ189503A NZ 189503 A NZ189503 A NZ 189503A NZ 189503 A NZ189503 A NZ 189503A NZ 18950379 A NZ18950379 A NZ 18950379A NZ 189503 A NZ189503 A NZ 189503A
Authority
NZ
New Zealand
Prior art keywords
benzodioxanes
aralkylamino
erythro
diastereomers
hydroxy
Prior art date
Application number
NZ189503A
Inventor
C F Huebner
H W Gschwend
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NZ189503A publication Critical patent/NZ189503A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ189503A 1978-01-30 1979-01-29 Diastereomers of erythro-2-(2-aralkylamino-1-hydroxy-ethyl)-1,4-benzodioxanes NZ189503A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87345778A 1978-01-30 1978-01-30

Publications (1)

Publication Number Publication Date
NZ189503A true NZ189503A (en) 1981-03-16

Family

ID=25361674

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ189503A NZ189503A (en) 1978-01-30 1979-01-29 Diastereomers of erythro-2-(2-aralkylamino-1-hydroxy-ethyl)-1,4-benzodioxanes

Country Status (18)

Country Link
EP (1) EP0003359B1 (en)
JP (1) JPS54112878A (en)
AT (1) ATA63379A (en)
AU (1) AU4375879A (en)
DD (1) DD142051A5 (en)
DE (1) DE2960137D1 (en)
DK (1) DK36879A (en)
ES (1) ES477280A1 (en)
FI (1) FI790270A (en)
GB (1) GB2013204A (en)
GR (1) GR71689B (en)
IE (1) IE790152L (en)
IL (1) IL56528A0 (en)
NO (1) NO790281L (en)
NZ (1) NZ189503A (en)
PL (1) PL213102A1 (en)
PT (1) PT69146B (en)
ZA (2) ZA786692B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2916089A (en) * 1987-12-18 1989-07-19 Schering Corporation Processes and compounds useful for resolving 1-methyl-3-phenylpropylamine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1038333A (en) * 1963-02-13 1966-08-10 Ici Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
ES477280A1 (en) 1979-10-16
GB2013204A (en) 1979-08-08
DD142051A5 (en) 1980-06-04
DK36879A (en) 1979-07-31
EP0003359A1 (en) 1979-08-08
DE2960137D1 (en) 1981-03-26
IE790152L (en) 1979-07-30
GR71689B (en) 1983-06-21
ZA786692B (en) 1979-11-28
PT69146B (en) 1981-06-11
JPS54112878A (en) 1979-09-04
AU4375879A (en) 1979-08-09
IL56528A0 (en) 1979-03-12
ATA63379A (en) 1981-07-15
NO790281L (en) 1979-07-31
FI790270A (en) 1979-07-31
ZA79364B (en) 1980-01-30
EP0003359B1 (en) 1981-02-11
PL213102A1 (en) 1980-02-25
PT69146A (en) 1979-02-01

Similar Documents

Publication Publication Date Title
GB2034210B (en) Chucks
IE790169L (en) Preparation of oligo-imides.
GB2015902B (en) Centrifuge
GB2027857B (en) Warhead
GB2026060B (en) Well treatment
JPS5518693A (en) Improved electrooopticallmodulator
NZ191462A (en) Derivatives of 2 ,16 -bis-piperidino-3 -hydroxy-5 -androstane-3 -esters
GB2025278B (en) Collets
JPS54129587A (en) Drill
GB2014983B (en) Substituted 2-phenylimino-imidazolidines
GB2031778B (en) Lathes
GB2039891B (en) Triazinones
JPS5596202A (en) Lathe
MY8300180A (en) Centrifuge
PH14741A (en) 3,5-dihalogeno-1,2-methylenedioxybenzene
GB2104524B (en) Derivatives of 1a, 25-dihydroxycholesterol
GB2035156B (en) Chucks
GB2030681B (en) Warhead
IL54980A0 (en) Centrifuge
NZ189503A (en) Diastereomers of erythro-2-(2-aralkylamino-1-hydroxy-ethyl)-1,4-benzodioxanes
GB2028309B (en) Dioxoles
JPS5542797A (en) Lathe
GB2016463B (en) 2-phenyl-5,6-dihydro-4-pyrone derivatives
GB2030036B (en) Direct drill
IL58268A (en) Preparation of n,n-dimethylaminoacetonitrile